Efficiency of phototherapy in patients with mycosis fungoides: preliminary results of a comparative non-randomized study
- Authors: Karamova A.E.1, Zhilova M.B.1, Znamenskaya L.F.1, Vorontsova A.A.1
-
Affiliations:
- State Research Center of Dermatovenereology and Cosmetology, Ministry of Health of the Russian Federation
- Issue: Vol 96, No 5 (2020)
- Pages: 24-30
- Section: ORIGINAL STUDIES
- URL: https://journals.rcsi.science/0042-4609/article/view/117534
- DOI: https://doi.org/10.25208/vdv1188-2020-96-5-24-30
- ID: 117534
Cite item
Full Text
Abstract
Clinical reasoning. There is a need to optimize the use of UV-B-311 nm and PUVA-therapy in patients with mycosis fungoides — to determine the duration of the treatment regimen, the number of sessions per week, and ultraviolet irradiation regimen.
Goal of research. Evaluation of the effect of the type and duration phototherapy on efficacy in patients with mycosis fungoides.
Principle. A comparative, non-randomized study of the effectiveness of phototherapy in patients with mycosis fungoides in the early stages. Evaluation of the effectiveness of UV-B-311 nm and PUVA therapy was performed using the BSA index (area of skin lesions) and Modified Severity-Weighted Assessment Tool (mSWAT), as well as according to the criteria proposed by the International Society for Skin Lymphomas (ISCL), the European Organization for the Study and Cancer Treatment (EORTC) and United States Cutaneous Lymphoma Consortium (USCLC).
Results. The study included 14 patients with mycosis fungoides, 5 of whom received treatment with UV-B-311 nm, 9 — PUVA therapy. A strong correlation was found between the duration of UV-B-311 nm therapy with mSWAT delta (R = 0.90; p = 0.038) and BSA delta (R = 0.90; p = 0.038), while similar correlation was not found in the PUVA-therapy group (mSWAT (R = –0.24; p = 0.527); BSA (R = –0.09; p = 0.823)). When comparing the effectiveness of therapy between the treatment group UV-B-311 nm and PUVA therapy, delta mSWAT and BSA at the 20th procedure, delta mSWAT and BSA after the end of therapy did not have a statistically significant difference between the UVB-311 nm and PUVA groups.
Conclusion. Statistically significant correlation was found between the number of procedures and the effectiveness of therapy In the UV-B-311 nm group. An increase in the number of PUVA therapy procedures (after 20) does not lead to a statistically significant increase in the effectiveness of treatment. Additional research is needed to increase the level of evidence of the results and develop optimal phototherapy regimens.
Full Text
##article.viewOnOriginalSite##About the authors
A. E. Karamova
State Research Center of Dermatovenereology and Cosmetology, Ministry of Health of the Russian Federation
Email: karamova@cnikvi.ru
ORCID iD: 0000-0003-3805-8489
SPIN-code: 3604-6491
к.м.н., заведующий отделом дерматологии
Russian Federation, Korolenko str., 3, bldg 6, Moscow, 107076, RussiaM. B. Zhilova
State Research Center of Dermatovenereology and Cosmetology, Ministry of Health of the Russian Federation
Email: zhilova@cnikvi.ru
SPIN-code: 8930-4073
д.м.н., заведующий отделением физиотерапии
Russian Federation, Korolenko str., 3, bldg 6, Moscow, 107076, RussiaL. F. Znamenskaya
State Research Center of Dermatovenereology and Cosmetology, Ministry of Health of the Russian Federation
Email: znaml@cnikvi.ru
ORCID iD: 0000-0002-2553-0484
SPIN-code: 9552-7850
д.м.н., ведущий научный сотрудник отдела дерматологии
Russian Federation, Korolenko str., 3, bldg 6, Moscow, 107076, RussiaA. A. Vorontsova
State Research Center of Dermatovenereology and Cosmetology, Ministry of Health of the Russian Federation
Author for correspondence.
Email: nastasia08@bk.ru
ORCID iD: 0000-0002-3129-0050
SPIN-code: 8334-2890
Junior researcher of department of dermatology
Russian Federation, Korolenko str., 3, bldg 6, Moscow, 107076, RussiaReferences
- Olek-Hrab K, Silny W, Dańczak‐Pazdrowska A, et al. Ultraviolet A1 phototherapy for mycosis fungoides. Clin Exp Dermatol 2013 Mar; 38(2):126–30. PMID: 23082901. doi: 10.1111/ced.12001
- Adışen E, Tektaş V, Erduran F, et al. Ultraviolet A1 Phototherapy in the Treatment of Early Mycosis Fungoides. Dermatology 2017;233:192–198. PMID: 28441652. doi: 10.1159/000458149
- Fujii M, Uehara J, Honma M, et al. Primary cutaneous cd-T-cell lymphoma treated with low-dose methotrexate and narrowband ultraviolet B irradiation: report of a case with testicular involvement. J Dermatol 2011;38:368–372.
- Phan K, Ramachandran V, Fassihi H, Sebaratnam DF. Comparison of Narrowband UV-B With Psoralen–UV-A Phototherapy for Patients With Early-Stage Mycosis Fungoides. A Systematic Review and Meta-analysis. JAMA Dermatol 2019. Published online January 30, 2019. doi: 10.1001/jamadermatol.2018.5204. PMID: 30698622
- Olsen EA, Whittaker S, Kim YH, et al. International Society for Cutaneous Lymphomas; United States Cutaneous Lymphoma Consortium; Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. J Clin Oncol. 2011;29(18):2598–2607. doi: 10.1200/JCO.2010.32.0630
- Stevens SR, Ke MS, Parry EJ, et al. Quantifying skin disease burden in mycosis fungoides-type cutaneous T-cell lymphomas: The severity-weighted assessment tool (SWAT) Arch Dermatol. 2002;138:42–48.
- Перечень редких (орфанных) заболеваний. https://minzdrav.gov.ru/documents/8048
Supplementary files
